Ivey Business School (Canada)
-
Pfizer and the Challenges of the Pharmaceutical Industry (A)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M076-EStrategyIn 2018, President of the United States, Donald Trump, criticized the company Pfizer Inc. (Pfizer) for increasing drug prices—which had been a strategic move by Pfizer in response to industry-wide challenges. This announcement highlighted the complex dynaStarting at €8.20
-
Uber(US): The Push for Autonomous Vehicles
Thompson S.H. Teo; Vivien K.G. LimCase IVEY-9B20D022-EService and Operations Management, StrategySince early 2015, Uber had been investing heavily in research and development for its autonomous vehicles to revolutionize the ride-hailing industry and provide better ways of competing and fulfilling its promise of profitability to investors. Constant inStarting at €8.20
-
Pfizer and the Challenges of the Pharmaceutical Industry (B)
Renate Kratochvil; Phillip C. NellCase IVEY-9B19M077-EStrategyCase B complements Case A, describing pharmaceutical companies’ strategic responses—such as mega-mergers and acquisitions and specialization—to industry-wide global challenges and highlights strategic decisions by Pfizer’s chief executive officers betweenStarting at €5.74